-
Did you mean
- like since
- life sige
-
Thiol Status ELISA (Sulfhydryl)Catalog #: 30-1800
Sample Types: Plasma, Serum, Synovial Fluids, Urine
Sample Size(s): 96 Wells
Detection: Colorimetric -
Anti-Ribosomal P IgG ELISA
Catalog #: 35-RIBHU-E01
Sensitivity: 1.0 U/mL
Range: 3 - 300 U/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Anti-SLA IgG ELISA
Catalog #: 35-SLAHU-E01
Sensitivity: 1.0 U/mL
Range: 3 - 300 U/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
PGE2 ELISA
Catalog #: 74-PG2HU-E01
Sensitivity: 13.4 pg/mL
Range: 39.1 - 2,500 pg/mL
Sample Types: Cell Culture, Saliva, Serum, Urine, Whole Blood
Sample Size(s): 96 Wells
Detection: Colorimetric -
C-Peptide ELISA
Catalog #: 80-CPTHU-E01.1
Sensitivity: 2.95 pmol/L
Range: 20 - 3000 pmol/L
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
C-Peptide ELISA Jumbo Pack (10 Plates)
Catalog #: 80-CPTHU-E10
Sensitivity: 2.95 pmol/L
Range: 20 - 3000 pmol/L
Sample Types: Plasma, Serum
Sample Size(s): 10 x 96 Wells
Detection: Colorimetric -
EHEC Verotoxin ELISA
Catalog #: 86-VTXHU-E01
Range: Cut-off Assay
Sample Types: Stool
Sample Size(s): 96 Wells
Detection: Colorimetric -
PGE2 ELISA 5 Plate
Catalog #: 74-PG2HU-E05
Sensitivity: 13.4 pg/mL
Range: 39.1 - 2,500 pg/mL
Sample Types: Cell Culture, Saliva, Serum, Urine, Whole Blood
Sample Size(s): 5 x 96 Wells
Detection: Colorimetric -
C-Peptide Chemiluminescence ELISACatalog #: 80-CPTHU-CH01
Sensitivity: <4.32 pg/mL
Range: 4.5 - 12,960 pg/mL
Sample Types: EDTA Plasma, Heparin Plasma, Plasma, Serum, Tissue Culture
Sample Size(s): 96 Wells
Detection: Chemiluminescence -
C-Peptide Chemiluminescence ELISA Lab Pack (5 Plates)Catalog #: 80-CPTHU-CH05
Sensitivity: <4.32 pg/mL
Range: 4.5 - 12,960 pg/mL
Sample Types: EDTA Plasma, Heparin Plasma, Plasma, Serum, Tissue Culture
Sample Size(s): 5 x 96 Wells
Detection: Chemiluminescence -
25-OH Free Vitamin D ELISA
Catalog #: 38-KAPF1991
Sensitivity: 1.9 pg/mL
Range: 0-40 pg/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Bioactive Leptin ELISA
Catalog #: 22-BLEPHU-E01
Sensitivity: < 0.01 ng/mL
Range: 0.05 - 6 ng/mL
Sample Types: EDTA Plasma, Heparin Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric
Responsibility
ALPCO’s Diabetes Research Travel GrantALPCO strives to provide scientists and healthcare professionals with robust tools for their research and clinical diagnostic endeavors. We understand that championing extraordinary discoveries requires extraordinary efforts, and support. We are proud to continu...
Alpco Home Page
New: Calprotectin Immunoturbidimetric Assay will take your testing to the next level. Learn more.Supporting your work with life science and clinical testing productsVIEW ALL LIFE SCIENCE PRODUCTSVIEW ALL CLINICAL DIAGNOSTIC PRODUCTS
Tips & Tricks
The Enzyme-Linked Immunosorbent Assay (ELISA) is a proven sensitive method for detecting and quantifying specific biomarkers in a wide range of clinical and research samples. The accuracy and precision of ELISAs can be affected by many factors, including pipetting, washing, and sample-handling techn...
Company Overview
Accuracy and Efficiency. Together.We are a leading global developer and provider of innovative molecular and immunodiagnostic products focused on Infectious and Gastroenterological Diseases. We are a trusted partner creating value for research and clinical laboratories with high-quality, user-frien...
Differentiating Gastrointestinal Pathogens from IBD and IBS
Gastrointestinal (GI) disorders such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), as well as infections from GI pathogens can present very similar symptoms. A host of tests have been developed to aid in the differentiation between IBD and IBS, such as calprotectin and lact...
Regulating Endocrine Disrupting Chemicals in Consumer Products
Date: September 27, 2016
Author: Andrea Tarbet, Product Marketing Associate at ALPCO
From cosmetics to water bottles, endocrine disrupting chemicals (EDCs) have surfaced in our everyday lives. EDCs are compounds that can interfere with the endocrine system’s ability to help an organism develop...
Endocrine Disrupting Chemicals and Biomarkers
Introduction
Humans and the environment are exposed to numerous chemicals every day1. Each year, about 2,000 new chemicals are manufactured in the U.S.2. Research findings over the years have shown how some chemicals known as endocrine disrupting chemicals (EDCs) can interact with the endocrine sys...
Choosing the Relevant GLP-1 Species to Study
A better understanding of incretins has led to tremendous therapeutic advances in the field of type 2 diabetes1. These hormones are released from the gut in response to food ingestion and lead to the stimulation of pancreatic β-cells which then release insulin in a glucose-concentration de...
MacroArray Diagnostics GmbH (MADx) partners with ALPCO to offer a fully automated sample-to-answer multiplex allergy test solution to the North American market
FOR IMMEDIATE RELEASE
Salem, NH – February 1, 2022:
ALPCO (Salem, NH), a leading US producer of novel immunoassay testing platforms, recently announced an exclusive distribution partnership with MacroArray Diagnostics GmbH (Vienna, Austria). Together they offer a comprehensive line of testing ...
American Laboratory Products Company Merges with GeneProof
SALEM, NH and BRNO, Czech Republic – April 21st, 2022: American Laboratory Products Company, Ltd. (“ALPCO”), a specialty in vitro diagnostics company, today announced a merger with GeneProof a.s. (“GeneProof”), a leading molecular diagnostics company based in Brno, Czech Republic. The combination cr...
Featured Biomarkers from A to Z
This handout briefly describes the role of several important hormones measured in research.
Thermo Fisher partners with ALPCO-GeneProof to broaden their CE-IVD molecular assay portfolio
BRNO, CZECH REPUBLIC, April 17, 2023 – ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with...
ALPCO-GeneProof Appoints Erik M. Allen as Chief Executive Officer
SALEM, N.H. and BRNO, Czech Republic, March 30, 2023 /PRNewswire/ -- American Laboratory Products Company, Ltd. ("ALPCO", or the "Company"), a global provider of specialty diagnostic solutions, today announced the appointment of Erik M. Allen as Chief Executive Officer (CEO). Mr....
ALPCO receives FDA 510(k) clearance for the Calprotectin Immunoturbidimetric Assay
SALEM, NH, June 15, 2023 - American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, today announced recent FDA 510(k) clearance of its Calprotectin Immunoturbidimetric Assay.
GeneProof Announces Expansion of its IVDR-Certified PCR Portfolio
GeneProof, a leader in molecular diagnostics, today announced the addition of six new IVDR-certified PCR kits to its expansive portfolio. This comes as a testament to the company’s dedication to delivering its entire portfolio of approximately 80 products as IVDR compliant by 2027. Currently, ...
ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay
Salem, NH, December 19, 2023 – American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, proudly announces the commercial launch of its FDA 510(k) cleared Calprotectin Immunoturbidimetric Assay, enhancing its suite of Gastrointestinal (GI) d...
Live Webinar: Optimizing IBD Management with Fecal Calprotectin - From Diagnosis to Monitoring
In the webinar, Dr. Benjamin Click from the University of Colorado, Department of Gastroenterology, underscores the critical role of non-invasive monitoring methods, particularly fecal calprotectin monitoring, in guiding treatment adjustments and achieving therapeutic goals..
Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings
Salem, NH, December 19, 2023 – Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the Euro...
Complement System Solutions for Drug Development and Clinical Research
Datasheet: Complement System Immunoassays
Download
The complement system is essential to innate immunity which protects from chronic, autoimmune, and infectious disease. There are three distinct pathways of complement activation: classical, lectin/MBL, and alternative. Each leads...
Heart Disease Biomarkers in Diabetes Research
Introduction
Cardiovascular disease (CVD) encompasses a constellation of diseases related to the heart and circulatory system. Despite efforts to understand and combat CVD complications from diabetes, 65% of diabetics will pass away from cardiovascular issues1. Part 2 of The Common Denominator eBoo...
Physiological Actions of Natriuretic Peptides
Introduction
Humans have at least 50 discovered hormones managing vital biological functions in the body. These hormones are produced by the body’s organs and glands. Natriuretic peptides (NPs) are structurally related hormones synthesized and released from the heart, including atrial natriuretic p...
Early Detection of Diabetic Kidney Disease with Biomarkers
Introduction
Over one third of diabetics will develop diabetic kidney disease (DKD) in their lifetime1. Despite the large amount of diabetics suffering from DKD, current methods for measuring and tracking kidney function may not be specific enough for diabetic systems2,3.
Part III of The Common ...
Investigating Bioactive Leptin in Obesity Research
The Biology of Leptin
Leptin is a hormone composed of 167 amino acids and is primarily produced by adipocytes, therefore providing a signal to the energy state of organisms. By binding to the leptin receptor, the analyte influences activity within the JAK-STAT pathway and thereby regulates energy m...
De-escalating Inflammatory Bowel Disease Therapies
Date: June 21, 2016
Author: Andrea Tarbet, Product Marketing Associate at ALPCO
Several therapies exist to help treat inflammatory bowel disease (IBD) and improve patient quality of life. However, a growing number of gastroenterologists and patients have been choosing to stop these therapies -...